Clinical Trial Update: A Pilot Study of Topical Antiflammin-2 for Psoriasis

View source ↗

Summary

A National Cancer Institute-sponsored pilot trial evaluating a topical antiflammin-2 for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Topical Antiflammin-2 (antiflammin-2)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Psoriasis | Status: COMPLETED